Published in J Soc Gynecol Investig on May 01, 2004
Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis. BMC Pregnancy Childbirth (2006) 0.83
Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis. PLoS One (2014) 0.81
Association of plasminogen activator inhibitor-type 1 (-675 4G/5G) polymorphism with pre-eclampsia: systematic review. PLoS One (2013) 0.77
Associations between nitric oxide synthase 3 gene polymorphisms and preeclampsia risk: a meta-analysis. Sci Rep (2016) 0.77
Polymorphisms of the endothelial nitric oxide synthase (NOS3) gene in preeclampsia: a candidate-gene association study. BMC Pregnancy Childbirth (2011) 0.75
Polymorphisms in the Estrogen Receptor Beta Gene and the Risk of Unexplained Recurrent Spontaneous Abortion. Avicenna J Med Biotechnol (2017) 0.75
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol (2009) 1.92
Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet (2011) 1.51
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol (2011) 1.50
Clinical recommendation radical trachelectomy for fertility preservation in patients with early-stage cervical cancer. Int J Gynecol Cancer (2012) 1.49
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer. Tumour Biol (2004) 1.46
Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies. Am J Obstet Gynecol (2011) 1.43
To butterfly or to needle: the pilot phase. Ann Intern Med (2004) 1.40
New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension (2013) 1.20
Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist (2009) 1.19
Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer. Obstet Gynecol (2007) 1.17
Perinatal lead and mercury exposure in Austria. Sci Total Environ (2010) 1.15
Uterosacral ligament in postmenopausal women with or without pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2005) 1.06
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo. Clin Cancer Res (2005) 1.05
Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial. Obstet Gynecol (2012) 1.03
Fibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer. Am J Obstet Gynecol (2009) 1.00
Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril (2009) 0.96
Obstetrical management of the older gravida. Womens Health (Lond Engl) (2010) 0.96
Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo. Fertil Steril (2006) 0.94
Macrophage-derived IL-33 is a critical factor for placental growth. J Immunol (2013) 0.93
Large-for-gestational-age newborns in women with insulin-treated gestational diabetes under strict metabolic control. Wien Klin Wochenschr (2005) 0.92
Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors. Int J Gynecol Cancer (2011) 0.92
Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines. Breast Cancer Res Treat (2003) 0.92
Periurethral connective tissue status of postmenopausal women with genital prolapse with and without stress incontinence. Acta Obstet Gynecol Scand (2003) 0.92
The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study. BMC Cancer (2009) 0.91
Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia. J Reprod Immunol (2007) 0.91
The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer. Int J Gynecol Cancer (2010) 0.90
O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. J Proteome Res (2009) 0.90
Prognostic factors and treatment-related outcome in patients with uterine papillary serous carcinoma. Anticancer Res (2007) 0.90
Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas. Fertil Steril (2006) 0.89
Serum levels of heat shock protein 70 in patients with preeclampsia: a pilot-study. Wien Klin Wochenschr (2002) 0.88
Lack of association of TNFalpha gene polymorphisms and recurrent pregnancy loss in Caucasian women. J Reprod Immunol (2004) 0.88
Polymorphisms associated with thrombophilia and vascular homeostasis and the timing of menarche and menopause in 728 white women. Menopause (2005) 0.87
Breast cancer diagnosed during pregnancy. Anticancer Res (2007) 0.87
Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia. Gynecol Oncol (2011) 0.87
Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. Int J Oncol (2003) 0.86
DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy. Fertil Steril (2004) 0.86
Severe diabetic fetopathy despite strict metabolic control. Wien Klin Wochenschr (2005) 0.86
N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial. Cardiovasc Diabetol (2011) 0.85
NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls. Acta Obstet Gynecol Scand (2009) 0.84
Ovarian transplantation for fertility preservation in a sheep model: can follicle loss be prevented by antiapoptotic sphingosine-1-phosphate administration? Gynecol Endocrinol (2009) 0.84
Vascular endothelial growth factor gene polymorphisms and risk of cervical intraepithelial neoplasia. Int J Gynecol Cancer (2011) 0.84
Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases. Gynecol Oncol (2003) 0.83
Quality of life and sexual functioning in endometrial cancer survivors. Gynecol Oncol (2010) 0.83
Recurrent pregnancy failure is associated with a polymorphism in the p53 tumour suppressor gene. Hum Reprod (2004) 0.83
European Society of Gynecological Oncology Task Force for Fertility Preservation: Clinical Recommendations for Fertility-Sparing Management in Young Endometrial Cancer Patients. Int J Gynecol Cancer (2015) 0.83
Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications. BMC Cancer (2013) 0.82
The prognostic role of human papillomavirus in patients with vaginal cancer. Int J Gynecol Cancer (2011) 0.82
Augmentation index and pulse wave velocity in normotensive and pre-eclamptic pregnancies. Acta Obstet Gynecol Scand (2013) 0.82
The accuracy of intraoperative frozen section of the inguinal sentinel lymph node in vulvar cancer. Anticancer Res (2009) 0.82
Association of C-reactive protein (CRP) gene polymorphisms, serum CRP levels and cervical cancer prognosis. Anticancer Res (2011) 0.82
Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: a multicenter study. J Soc Gynecol Investig (2004) 0.82
Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy. Anticancer Res (2003) 0.82
Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study. Gynecol Endocrinol (2010) 0.81
Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand (2002) 0.81
Estimates of global research productivity in gynecologic oncology. Int J Gynecol Cancer (2009) 0.81
Concentrations of estrogens in patients with preeclampsia. Wien Klin Wochenschr (2002) 0.81
The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer. Eur J Obstet Gynecol Reprod Biol (2013) 0.81
Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer. Gynecol Oncol (2002) 0.81
The prognostic value of four interleukin-1 gene polymorphisms in Caucasian women with breast cancer: a multicenter study. BMC Cancer (2009) 0.81
Elevated serum concentrations of androgens in women with pregnancy-induced hypertension. Wien Klin Wochenschr (2003) 0.81
Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women. J Soc Gynecol Investig (2003) 0.80
Primary uterine leiomyosarcoma and primary atypical meningioma diagnosed during pregnancy. Anticancer Res (2008) 0.80
Histological category and expression of hormone receptors in ductal carcinoma in situ of the breast. Anticancer Res (2002) 0.80
Accuracy of preoperative vulva biopsy and the outcome of surgery in vulvar intraepithelial neoplasia 2 and 3. Int J Gynecol Pathol (2009) 0.80
Primitive neuroectodermal tumor (PNET) of the brain diagnosed during pregnancy. Anticancer Res (2006) 0.80
Circulating levels of MCP-1 are increased in women with gestational diabetes. Prenat Diagn (2008) 0.80
The C46T polymorphism of the coagulation factor XII gene and idiopathic recurrent miscarriage. BJOG (2005) 0.79
Fertility preserving management in gynecologic cancer patients: the need for centralization. Int J Gynecol Cancer (2010) 0.79
Ten polymorphisms of estrogen-metabolizing genes and a family history of colon cancer--an association study of multiple gene-gene interactions. J Soc Gynecol Investig (2005) 0.79
The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer. Anticancer Res (2002) 0.79
Live birth after in vitro fertilization and single embryo transfer in a kidney transplant patient: a case report and review of the literature. J Assist Reprod Genet (2010) 0.79
The impact of plasma fibrinogen levels on patients with vulvar cancer. Eur J Obstet Gynecol Reprod Biol (2012) 0.78
TNFalpha -308 C-->t and -863 C-->a polymorphisms and spermiogram characteristics. Gynecol Obstet Invest (2008) 0.77
Influence on fetal blood pH when adding amniotic fluid: an in vitro model. BJOG (2003) 0.77
Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene. Am J Reprod Immunol (2009) 0.77
Mental well-being in 5000 women participating in the 'Women-Plus' preventive medicine program. Maturitas (2002) 0.76
Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand (2006) 0.76
Spread of endometriosis to pelvic sentinel lymph nodes: gene expression analysis. Eur J Obstet Gynecol Reprod Biol (2013) 0.76
Polymorphism of the interleukin-1beta gene and endometriosis. J Soc Gynecol Investig (2003) 0.76
Expression of the von Hippel-Lindau gene protein in breast cancer tissue. Gynecol Oncol (2002) 0.76
Serum levels of squamous cell carcinoma antigen as a predictor of inguinofemoral lymph node metastasis in patients with vulvar cancer. J Reprod Med (2002) 0.76
Comparison of a reusable with a disposable vessel-sealing device in a sheep model: efficacy and costs. Fertil Steril (2010) 0.75
The sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med (2016) 0.75
Correction: Methylation Markers for the Identification of Body Fluids and Tissues from Forensic Trace Evidence. PLoS One (2016) 0.75
The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer. Eur J Obstet Gynecol Reprod Biol (2010) 0.75
Total mesometrial resection. Lancet Oncol (2005) 0.75
Surgical treatment of endometrial cancer: does closure or non-closure of the vagina affect the local recurrence rate? Anticancer Res (2007) 0.75
An Angiopoietin-2 gene polymorphism in unexplained intrauterine fetal death: a multi-center study. J Reprod Immunol (2005) 0.75
An interleukin-6 gene promoter polymorphism and unexplained late intrauterine fetal death: a multicenter study. J Soc Gynecol Investig (2005) 0.75
Severe early onset hemolysis, elevated liver enzyme, and low platelet-syndrome in 2 subsequent pregnancies: case report and review of the literature. Arch Gynecol Obstet (2009) 0.75
Preeclampsia - a risk factor for osteoporosis? Analysis of maternal Sclerostin levels and markers of bone turnover in patients with pre-eclampsia. Hypertens Pregnancy (2014) 0.75
Expression of epidermal growth factor receptor and vascular endothelial growth factor in vaginal squamous cell cancer. Am J Obstet Gynecol (2010) 0.75
Reduction of preeclampsia in multiple pregnancies by a dedicated monitoring protocol. J Soc Gynecol Investig (2003) 0.75
Polymorphisms within the interleukin-1 gene family and unexplained late intrauterine fetal death: a multi-center study. Am J Reprod Immunol (2005) 0.75
Polymorphisms of the Nos3 gene and unexplained late intrauterine fetal death. Eur J Obstet Gynecol Reprod Biol (2005) 0.75
Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial. J Matern Fetal Neonatal Med (2005) 0.75
Forced coughing versus local anesthesia and pain associated with cervical biopsy: a randomized trial. Am J Obstet Gynecol (2008) 0.75